Virtu Financial LLC purchased a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,218 shares of the medical research company’s stock, valued at approximately $672,000. Several other hedge funds also recently [...]